http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105920019-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2016-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105920019-B |
| titleOfInvention | A kind of pharmaceutical composition and its application in preparation of anti-tumor drugs containing ursolic acid and Sorafenib |
| abstract | The present invention relates to a kind of antitumor medicine composition and its application in preparations of anti-tumor drugs, it is characterised in that the amount ratio for including substance is 1 10:The amount ratio of 1 30 ursolic acid and Sorafenib, the wherein substance of ursolic acid and Sorafenib is preferably 1:3.The composition has the antitumor activity of high-efficiency low-toxicity. |
| priorityDate | 2016-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.